查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1643510

病人參與人工智慧的全球市場

Artificial Intelligence in Patient Engagement
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 248 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球病人參與人工智慧市場規模預計將達到 231 億美元

2024 年全球人工智慧患者病人參與市場規模估計為 80 億美元，預計到 2030 年將達到 231 億美元，2024 年至 2030 年的複合年成長率為 19.4%。雲端基礎的交付模式是報告中分析的細分市場之一，預計到分析期結束時複合年成長率將達到 21.7%，達到 184 億美元。在分析期間內，現場交付模式部分的複合年成長率預計為 12.8%。

美國市場預計將達到 21 億美元，中國市場年複合成長率將達到 18.3%

預計到 2024 年，美國病人參與人工智慧市場規模將達到 21 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 35 億美元，2024-2030 年分析期間的複合年成長率為 18.3%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 18.0% 和 16.4%。在歐洲，預計德國的複合年成長率約為 13.0%。

全球病人參與人工智慧市場 - 主要趨勢和促進因素摘要

人工智慧將如何改變病人參與？

人工智慧 (AI) 透過提供個人化護理、改善溝通以及讓患者積極參與管理自己的健康，徹底改變了病人參與。傳統的病人參與方法通常依賴手動互動和標準化方法，無法有效滿足個人需求。人工智慧利用機器學習 (ML)、自然語言處理 (NLP) 和預測分析來提供個人化和有意義的患者體驗，從而解決這些挑戰。

人工智慧聊天機器人和虛擬助理提供全天候支持，回答患者的疑問、安排預約、發送藥物提醒等。這些工具提高了可近性，同時減輕了醫療保健提供者的管理負擔。此外，人工智慧系統可以分析患者資料並提供個人化的健康提案，確保參與策略符合個人偏好和病歷。

此外，人工智慧還將透過行動應用程式、入口網站和穿戴式裝置提供客製化內容，加強對患者的教育。這些平台提供有關健康狀況、治療方案和生活方式改變的見解，以促進明智的決策。透過實現持續的、情境感知的參與，人工智慧正在改變患者與醫療服務互動的方式。

推動人工智慧在病人參與的應用的因素有哪些？

對個人化和高效醫療保健體驗的需求日益成長，是推動病人參與採用人工智慧的主要驅動力。隨著患者越來越要求滿足其獨特需求的客製化護理，人工智慧解決方案提供客製化的溝通和支持，以提高滿意度和治療效果。這些工具可以滿足不同患者的偏好，從數位技術嫻熟的患者到需要更多指導的患者。

遠端醫療和遠距會診模式的興起也刺激了人工智慧的採用。隨著虛擬訪問變得越來越普遍，人工智慧主導的平台透過為患者提供自我監測、症狀追蹤和虛擬跟進的工具來填補這一空白。這些能力可以確保護理的連續性，同時改善偏遠和服務不足地區患者的治療機會。

此外，資料整合和互通性的進步使得人工智慧系統能夠跨多個接觸點提供無縫的病人參與。透過分析電子健康記錄(EHR)、穿戴式裝置和健康應用程式的資料，AI 可以建立患者病人歷程的統一視圖，以提供一致、有影響力的互動。這些趨勢強調了人工智慧在重塑病人參與策略方面日益成長的重要性。

人工智慧可以改善健康結果和患者滿意度嗎？

透過提供主動、個人化的護理，人工智慧正在顯著改善健康結果和患者滿意度。預測分析工具可以識別患有慢性疾病和併發症風險的患者，以便及時介入並降低住院的可能性。例如，人工智慧系統可以監測生命徵象和生活方式資料，以檢測糖尿病和心臟病等疾病的早期預警訊號，使醫療保健提供者能夠採取預防措施。

透過自動化日常任務和改善護理協調，人工智慧減少了常常導致患者不滿的管理效率低下。即時更新、自動預約提醒以及輕鬆存取醫療資訊讓患者隨時了解情況並參與護理。這些功能改善了患者的整體體驗並提高了治療計劃的依從性。

人工智慧還可以透過提供壓力管理、正念和行為療法工具來支持心理健康和福祉。虛擬助理解決患者照護的情感方面的問題，提供個人化的建議和應對策略。這些技術創新有助於整體醫療保健並改善身心健康。

是什麼推動了病人參與市場人工智慧的成長？

病人參與市場中人工智慧的成長受到幾個關鍵因素的推動，這些因素反映了其在醫療保健領域的變革潛力。對以患者為中心的護理模式的日益關注，促使醫療保健提供者採用人工智慧工具來改善溝通並提供個人化的體驗。這些解決方案可協助組織與患者建立更牢固的關係，提高忠誠度和信任度。

人工智慧的技術進步，包括機器學習、NLP 和即時分析，正在擴展病人參與平台的功能。這些工具提供可操作的見解，使醫療保健提供者能夠預測患者的需求並提供主動支援。

消費者行為趨勢，例如對數位健康解決方案的偏好日益成長，正在進一步推動市場成長。患者正在使用行動應用程式、穿戴式裝置和虛擬助理作為有效管理健康的工具。此外，促進基於價值的護理和病人參與舉措的監管獎勵正在推動人工智慧在醫療保健領域的應用。

這些因素，加上對數位健康技術不斷增加的投資，正在推動人工智慧市場在病人參與的快速擴張，並將其定位為未來醫療保健服務和以患者為中心的服務創新的基石。

部分

交付格式（雲端基礎的交付格式、本地交付格式）、功能（增強通訊功能、聊天機器人和虛擬健康助理功能、預測分析功能、病患教育功能、其他功能）、技術（自然語言處理（NLP 技術、其他技術）、治療領域（慢性病管理治療領域、健康與保健治療領域、其他治療領域）、最終用戶（醫療服務提供者最終用戶、醫療服務付款人最終用戶、其他最終用戶）

受訪公司範例（52家值得關注的公司）

  • Ada Health GmbH
  • AiCure
  • Aiva
  • AllazoHealth
  • Brand Engagement Network, Inc.
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • IBM Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP29263

Global Artificial Intelligence in Patient Engagement Market to Reach US$23.1 Billion by 2030

The global market for Artificial Intelligence in Patient Engagement estimated at US$8.0 Billion in the year 2024, is expected to reach US$23.1 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2024-2030. Cloud-based Delivery Mode, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$18.4 Billion by the end of the analysis period. Growth in the On-Premise Delivery Mode segment is estimated at 12.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 18.3% CAGR

The Artificial Intelligence in Patient Engagement market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 18.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.0% and 16.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Artificial Intelligence in Patient Engagement Market - Key Trends & Drivers Summarized

How Is AI Transforming Patient Engagement?

Artificial Intelligence (AI) is revolutionizing patient engagement by delivering personalized care, improving communication, and empowering patients to take an active role in their health management. Traditional patient engagement methods often rely on manual interactions and standardized approaches that fail to address individual needs effectively. AI addresses these challenges by leveraging machine learning (ML), natural language processing (NLP), and predictive analytics to create tailored and meaningful patient experiences.

AI-powered chatbots and virtual assistants provide 24/7 support, answering patient queries, scheduling appointments, and sending medication reminders. These tools enhance accessibility while reducing the administrative burden on healthcare providers. In addition, AI systems analyze patient data to offer personalized health recommendations, ensuring that engagement strategies align with individual preferences and medical histories.

Moreover, AI enhances patient education by delivering customized content through mobile apps, portals, and wearable devices. These platforms provide insights into health conditions, treatment options, and lifestyle changes, fostering informed decision-making. By enabling continuous and context-aware engagement, AI is transforming the way patients interact with healthcare services.

What Drives the Adoption of AI in Patient Engagement?

The growing demand for personalized and efficient healthcare experiences is a major driver of AI adoption in patient engagement. As patients increasingly seek customized care that addresses their unique needs, AI-powered solutions offer tailored communication and support that enhances satisfaction and outcomes. These tools cater to diverse patient preferences, from digital-savvy individuals to those requiring more guidance.

The rise of telemedicine and remote care models is also fueling AI adoption. With virtual consultations becoming more prevalent, AI-driven platforms bridge the gap by providing patients with tools for self-monitoring, symptom tracking, and virtual follow-ups. These capabilities ensure continuity of care while improving access for patients in remote or underserved areas.

Additionally, advancements in data integration and interoperability are enabling AI systems to provide seamless patient engagement across multiple touchpoints. By analyzing data from electronic health records (EHRs), wearable devices, and health apps, AI creates a unified view of the patient journey, ensuring consistent and impactful interactions. These trends underscore the growing importance of AI in reshaping patient engagement strategies.

Can AI Enhance Health Outcomes and Patient Satisfaction?

AI is significantly enhancing health outcomes and patient satisfaction by fostering proactive and personalized care. Predictive analytics tools identify patients at risk of chronic conditions or complications, enabling timely interventions and reducing the likelihood of hospitalizations. For example, AI systems monitor vital signs and lifestyle data to detect early warning signs of conditions such as diabetes or heart disease, allowing healthcare providers to take preventive action.

By automating routine tasks and improving care coordination, AI reduces administrative inefficiencies that often lead to patient dissatisfaction. Real-time updates, automated appointment reminders, and easy access to medical information empower patients to stay informed and engaged in their care. These capabilities enhance the overall patient experience while ensuring better adherence to treatment plans.

AI also supports mental health and well-being by providing tools for stress management, mindfulness, and behavioral therapy. Virtual mental health assistants deliver personalized recommendations and coping strategies, addressing the emotional aspects of patient care. These innovations contribute to holistic health management, improving both physical and mental well-being.

What’s Driving the Growth of the AI in Patient Engagement Market?

The growth in the Artificial Intelligence in Patient Engagement market is driven by several critical factors, reflecting its transformative potential in healthcare. The increasing focus on patient-centric care models is encouraging healthcare providers to adopt AI tools that improve communication and deliver personalized experiences. These solutions help organizations build stronger relationships with patients, enhancing loyalty and trust.

Technological advancements in AI, including machine learning, NLP, and real-time analytics, are expanding the capabilities of patient engagement platforms. These tools provide actionable insights that enable healthcare providers to anticipate patient needs and deliver proactive support.

Consumer behavior trends, such as the growing preference for digital health solutions, are further driving market growth. Patients are embracing mobile apps, wearable devices, and virtual assistants as tools to manage their health effectively. Additionally, regulatory incentives promoting value-based care and patient engagement initiatives are supporting the adoption of AI in healthcare.

These factors, coupled with increasing investments in digital health technologies, are propelling the rapid expansion of the AI in Patient Engagement market, positioning it as a cornerstone of future innovation in healthcare delivery and patient-centric services.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Patient Engagement market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Delivery Mode (Cloud-based Delivery Mode, On-Premise Delivery Mode); Functionality (Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality, Other Functionalities); Technology (Natural Language Processing (NLP) Technology, Other Technologies); Therapeutic Area (Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area, Other Therapeutic Areas); End-Use (Healthcare Providers End-Use, Healthcare Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Ada Health GmbH
  • AiCure
  • Aiva
  • AllazoHealth
  • Brand Engagement Network, Inc.
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • IBM Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Patient Engagement - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Real-Time AI Chatbots Expand Opportunities for Enhancing Patient Communication
    • AI for Personalized Health Recommendations Strengthens Case for Proactive Engagement
    • AI-Driven Virtual Health Assistants Spur Growth in Home-Based Care Models
    • AI for Appointment Scheduling Optimizes Patient Flow, Driving Market Adoption
    • AI in Medication Adherence Monitoring Highlights Opportunities in Chronic Disease Management
    • AI-Powered Health Education Platforms Expand Addressable Market for Wellness Apps
    • Growing Demand for AI in Telehealth Sets the Stage for Patient-Centric Engagement Tools
    • AI for Remote Monitoring Systems Strengthens Case for Continuous Patient Interaction
    • AI for Multilingual Support Tools Bodes Well for Global Patient Engagement Markets
    • Integration of AI in Family Health Management Strengthens Use Cases in Collaborative Care
    • AI for Seamless Billing and Insurance Queries Drives Adoption in Revenue Cycle Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Patient Engagement Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cloud-based Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cloud-based Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for On-Premise Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for On-Premise Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Disease Management Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Chronic Disease Management Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Health & Wellness Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Health & Wellness Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Healthcare Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Healthcare Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enhanced Communication Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Enhanced Communication Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chatbots & Virtual Health Assistants Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Chatbots & Virtual Health Assistants Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Predictive Analytics Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Predictive Analytics Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Patient Education Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Patient Education Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Functionalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Natural Language Processing (NLP) Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Natural Language Processing (NLP) Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 64: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 94: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • ITALY
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 114: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 124: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 144: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 154: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030

IV. COMPETITION